How does 9F7's PE Ratio compare to its peers?

9F7 is expensive based on its Price-To-Earnings Ratio (9.8x) compared to the peer average (8.2x).

How does 9F7's PE Ratio compare vs other companies in the DE Capital Markets Industry?

9F7 is good value based on its Price-To-Earnings Ratio (9.8x) compared to the German Capital Markets industry average (20.3x).

What is 9F7's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

9F7 is good value based on its Price-To-Earnings Ratio (9.8x) compared to the estimated Fair Price-To-Earnings Ratio (15.4x).

What is the Fair Price of 9F7 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

9F7 (€14.01) is trading below our estimate of [[fair value]] (€35.48)

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Target price is less than 20% higher than the current share price.

Trinity Capital (DB:9F7) - Stock Price, News & Analysis

9F7 Stock Overview

A business development company. More details

9F7 fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	4/6
Past Performance	4/6
Financial Health	0/6
Dividends	2/6

Rewards

Trading at 60.5% below our estimate of its fair value

Earnings are forecast to grow 21.29% per year

Earnings grew by 51.8% over the past year

Risk Analysis

Interest payments are not well covered by earnings

High level of non-cash earnings

Dividend of 14.09% is not well covered by earnings or free cash flows

Shareholders have been diluted in the past year

Trinity Capital Inc. Competitors

MLP

XTRA:MLP

€644.9m

AURELIUS Equity Opportunities SE KGaA

HMSE:AR4

€394.9m

Ernst Russ

XTRA:HXCK

€190.7m

OVB Holding

XTRA:O4B

€283.6m

Price History & Performance

Summary of all time highs, changes and price drops for Trinity Capital
Historical stock prices
Current Share Price	US$14.01
52 Week High	US$14.31
52 Week Low	US$11.79
Beta	0.61
11 Month Change	12.26%
3 Month Change	11.99%
1 Year Change	6.14%
33 Year Change	-3.38%
5 Year Change	n/a
Change since IPO	12.31%

Recent updates

Shareholder Returns

	9F7	DE Capital Markets	DE Market
7D	4.8%	0.4%	1.1%
1Y	6.1%	25.5%	7.2%

Return vs Industry: 9F7 underperformed the German Capital Markets industry which returned 25.5% over the past year.

Return vs Market: 9F7 underperformed the German Market which returned 7.2% over the past year.

Price Volatility

Is 9F7's price volatile compared to industry and market?
9F7 volatility
9F7 Average Weekly Movement	4.0%
Capital Markets Industry Average Movement	4.2%
Market Average Movement	4.8%
10% most volatile stocks in DE Market	10.9%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: 9F7 has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: 9F7's weekly volatility (4%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	86	Kyle Brown	www.trinitycap.com

Trinity Capital Inc. is a business development company. It is a venture capital firm specializing in growth capital, innovative medical devices, venture debt to growth stage companies looking for loans and/or equipment financing, generate current income and, to a lesser extent, capital appreciation through investments, including term loans and equity-related investments. Trinity Capital Inc. was founded in 2019 is based in Phoenix, Arizona with additional offices in the United States.

Trinity Capital Inc. Fundamentals Summary

How do Trinity Capital's earnings and revenue compare to its market cap?
9F7 fundamental statistics
Market cap	€808.35m
Earnings (TTM)	€82.87m
Revenue (TTM)	€194.43m

9.8x

P/E Ratio

4.2x

P/S Ratio

Is 9F7 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
9F7 income statement (TTM)
Revenue	US$205.16m
Cost of Revenue	US$0
Gross Profit	US$205.16m
Other Expenses	US$117.72m
Earnings	US$87.44m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	1.48
Gross Margin	100.00%
Net Profit Margin	42.62%
Debt/Equity Ratio	120.6%

How did 9F7 perform over the long term?

See historical performance and comparison

Dividends

14.1%

Current Dividend Yield

114%

Payout Ratio

9F7 Stock Overview

Rewards

Risk Analysis

Trinity Capital Inc. Competitors

XTRA:MLP

€644.9m

HMSE:AR4

€394.9m

XTRA:HXCK

€190.7m

XTRA:O4B

€283.6m

Price History & Performance

Recent News & Updates

Founder & Executive Chairman recently bought €233k worth of stock

Trinity Capital Inc. announced that it has received $142.5 million in funding

Second quarter dividend of US$0.51 announced

Trinity Capital Inc. Announces Appointment of Joshua Ruben as Managing Director of Life Sciences

First quarter dividend of US$0.51 announced

Trinity Capital Inc. Appoints Craig Fox as Managing Director

Recent updates

Founder & Executive Chairman recently bought €233k worth of stock

Trinity Capital Inc. announced that it has received $142.5 million in funding

Second quarter dividend of US$0.51 announced

Trinity Capital Inc. Announces Appointment of Joshua Ruben as Managing Director of Life Sciences

First quarter dividend of US$0.51 announced

Trinity Capital Inc. Appoints Craig Fox as Managing Director

Trinity Capital Inc. Announces Director Appointments

New major risk - Earnings quality

Trinity Capital Inc., Annual General Meeting, Jun 12, 2024

Upcoming dividend of US$0.51 per share

Fourth quarter dividend of US$0.51 announced

Trinity Capital Inc. to Report Q1, 2024 Results on May 01, 2024

Trinity Capital Inc. Appoints Brendan Carr as Director of Tech Lending

Trinity Capital Inc. Announces Chief Financial Officer Changes

Trinity Capital Inc. Appoints Ryan Kaeding as Managing Director, Life Sciences in San Diego, California

Showroom Interiors LLC acquired Feather Home Inc. and Fernished, Inc.

Trinity Capital Inc. Declares Cash Dividend for the Quarter Ending September 30, 2023, Payable on October 13, 2023

Trinity Capital Inc. Announces Regular Cash Dividend, Payable on October 13, 2023

Upcoming dividend of US$0.54 per share at 13% yield

Trinity Capital Inc. Announces Management Changes

Trinity Capital Inc. Announces Management Changes

Trinity Capital Inc. has completed a Follow-on Equity Offering in the amount of $75 million.

New minor risk - Shareholder dilution

A group of buyers led by Fall Line Endurance Fund, Lp, managed by Fall Line Capital, LLC completed the acquisition of GreenLight Biosciences Holdings (NasdaqGM:GRNA) from stockholders.

Trinity Capital Inc. Appoints Andrew Ghannam as Managing Director of Tech Lending

Upcoming dividend of US$0.53 per share at 14% yield

Trinity Capital Inc. Declares Cash Dividend for the Quarter Ending June 30, 2023, Payable on July 14, 2023

Upcoming dividend of US$0.47 per share at 14% yield

Trinity Capital Inc. to Report Q3, 2023 Results on Nov 02, 2023

Molekule Group, Inc. (NasdaqCM:MKUL) acquired Molekule, Inc.

Trinity Capital Inc. Declares Cash Dividend for the Quarter Ending December 31, 2022, Payable on January 13, 2023

President recently bought €226k worth of stock

Intelligent Foods acquired Gobble Inc.

Trinity Capital Inc. (NasdaqGS:TRIN) announces an Equity Buyback for $25 million worth of its shares.

High number of new directors

AeroClean Technologies, Inc. (NasdaqCM:AERC) entered into a definitive agreement to acquire Molekule, Inc.

AeroClean Technologies, Inc. (NasdaqCM:AERC) entered into a definitive agreement to acquire Molekule, Inc.

Trinity Capital Inc. Appointment of Lauren Cosentino as Managing Director, Life Sciences in the Research Triangle Park Region of North Carolina

Trinity Capital Inc. Declares Cash Dividend for the Third Quarter of 2022, Payable on October 14, 2022

Trinity Capital Inc. has completed a Follow-on Equity Offering in the amount of $55 million.

Chairman & CEO recently bought €382k worth of stock

Trinity Capital Inc. to Report Q2, 2022 Results on Aug 04, 2022

Upcoming dividend of US$0.57 per share

Trinity Capital Inc. Declares Cash Dividend for the Second Quarter of 2022, Payable on July 15, 2022

Independent Director recently bought €71k worth of stock

President recently bought €118k worth of stock

Trinity Capital Inc. Proposes Special Dividends for the first, second, third and fourth quarters of 2022

Trinity Capital Inc. Announces Executive Changes

Less than half of directors are independent

Trinity Capital Inc. to Report Q1, 2022 Results on May 09, 2022

Trinity Capital Inc. Appoints Rob Lake as Managing Director

Trinity Capital Inc. has completed a Follow-on Equity Offering in the amount of $50.000346 million.

Trinity Capital Inc. has completed a Follow-on Equity Offering in the amount of $50 million.

Trinity Capital Inc. (NasdaqGS:TRIN) and RLG Capital, LLC acquired an 80% stake in Kamaka Air, Inc. from Jim Petrides and John Gravener.

Trinity Capital Inc. to Report Q4, 2021 Results on Mar 03, 2022

Less than half of directors are independent

Upcoming dividend of US$0.33 per share

Chief Legal Officer & Chief Compliance Officer Scott Harvey has left the company

Independent Director recently bought €59k worth of stock